obezitatea într-o comunitate rurală din judeţul iaşi - Gr.T. Popa

44
111. Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance – the
emerging role of the adipocyte as an endocrine organ. N Engl J Med
2001;345(18):1345-1346.
112. Graur M. Complicaţiile hepatice ale obezităţii. În: Graur M, editor. Obezitatea.
Editura Junimea, Iaşi, 2004, 331-342.
113. Bellentani S, Tiribelli C, Saccoccio G et al. Prevalence of chronic liver disease in
the general population of northern Italy: the Dionysos Study group. Hepatology
1994;20:1442-1449.
114. Ludwig J, Viggiano TR, McGill DB et al. Nonalcoholic steatohepatitis. Mayo
Clinic experiences with a hepatic unnamed disease. Mayo Clin Proc 1980; 55:
434-438.
115. Ludwig J, McGill DB, Lindor KD. Nonalcoholic steatohepatitis. J Gastroenterol
Hepatol 1997;12:398-403.
116. James OFW, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of
emerging identity and importance. J Hepatol 1998;29:495-501.
117. Ikai E, Ishizachi M, Suzuki Y, Ishida M, Noborizaka Y, Yamada Y. Association
between hepatic steatosis, insulin resistance and hyperinsulinemia as related to
hypertension in alcohol consumers and obese people. L Hum Hypertens 1995;
9: 102-105.
118. Bacon BR, Farahvash MJ, Janney CG et al. Nonalcoholic steatohepatitis: an
expanded clinical entity. Gastroenterology 1994;107:1103-1109.
119. Pagano G, Pacini G, Musso G et al. Nonalcoholic steatohepatitis, insulin
resistance and metabolic syndrome: further evidence for an etiologic association.
Hepatology 2002;35:367-372.
120. Ratziu V, Giral P, Charlotte F et al. Liver fibrosis in overweight patients.
Gastroenterol 2000;118:1117-1123.
121. Kern Wh, Heger AH, Payne JH. Fatty metamorphosis of the liver in morbid
obesity. Arch Pathol 1973;96:342-346.
122. Andersen T, Gluud C. Liver morphology in morbid obesity: a literature survey. Int
J Obes 1984;8:97-106.
123. Botnariu G. Obezitatea şi patologia osteoarticulară. În: Graur M, editor.
Obezitatea. Editura Junimea, Iaşi, 2004, 303-314.
124. Felson DT, Edmond SL. Orthopedic complications. In: Felson DT, editor.
Endocrinology. 1988, 399-412.
125. Sinkov V, Cymet T. Osteoarthritis: understanding the pathophysiology, genetics
and treatments. J Nat Med Assoc 2003;95(6):475-482.
126. Felson DT et al. An up-date of the epidemiology of knee and hip osteoarthritis
with a view oto prevention. Arthritis Rheum 1998; 41: 1343-1345.
127. Felson DT, Anderson JJ et al. Obesity and knee osteoarthritis. The Framingham
Study. Ann Intern Med 1988;109(1):18-24.
128. Mihai B. Obezitatea şi cancerul. În: Graur M, editor. Obezitatea. Editura Junimea,
Iaşi, 2004, 315-330.
129. Grundy SM, Barnett JP. Metabolic and health complications of obesity. Dis Mon
1990;36:645.
130. Wolff GL. Body weight and cancer. Am J Clin Nutr 1987;45:168.